Back to search

Prognostic Factors for Survival in Human Immunodeficiency Virus–associated Pulmonary Arterial Hypertension

Data up to Jan 2025

Published2003
Citations318
References27
Clinical Trials (1)

Total Citations Per Year

Abstract

References (27)

Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

1998 • 9,382 citations

A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

1996 • 2,590 citations

Primary Pulmonary Hypertension

1987 • 2,027 citations

Primary Pulmonary Hypertension

1997 • 1,748 citations

The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension

1992 • 1,541 citations

Pulmonary Arterial Hypertension

2004 • 1,457 citations

Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension

2000 • 1,445 citations

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension

2002 • 1,383 citations

Changing patterns of mortality across Europe in patients infected with HIV-1

1998 • 1,284 citations

Familial Primary Pulmonary Hypertension (Gene PPH1) Is Caused by Mutations in the Bone Morphogenetic Protein Receptor–II Gene

2000 • 1,184 citations

Antiretroviral Therapy for HIV Infection in 1998

1998 • 1,035 citations

Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family

2000 • 725 citations

Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary Hypertension

1998 • 674 citations

Primary Pulmonary Hypertension

2000 • 361 citations

Primary Pulmonary Hypertension in HIV Infection

1991 • 348 citations

Blind Analysis of Denaturing High-Performance Liquid Chromatography as a Tool for Mutation Detection

1998 • 341 citations

HIV-Related Pulmonary Hypertension

2000 • 330 citations

HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study.

1997 • 303 citations

Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension

1998 • 286 citations

Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension.

1994 • 239 citations

BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives

2002 • 207 citations

Impact of Highly Active Antiretroviral Therapy in HIV-positive Patients with Cardiac Involvement

2000 • 198 citations

Epoprostenol (Prostacyclin) Therapy in HIV-associated Pulmonary Hypertension

2000 • 175 citations

New Treatments for Pulmonary Arterial Hypertension

2002 • 153 citations

Membranoproliferative glomerulonephritis and plexogenic pulmonary arteriopathy in a homosexual man with acquired immunodeficiency syndrome

1987 • 147 citations

RISK FACTORS FOR PULMONARY ARTERIAL HYPERTENSION

2001 • 140 citations

Human Immunodeficiency Virus Infection and Pulmonary Hypertension: Two New Cases and a Review of 86 Reported Cases

1998 • 137 citations

Cited By (0)

Loading...